Hepatology
Development and validation of a prognostic nomogram for older patients with acute-on-chronic liver diseases
15 Jan, 2023 | 19:46h | UTCSee also: dynamic nomogram
Review | The pathogenesis and therapeutic strategies of heat stroke-induced liver injury
13 Jan, 2023 | 13:07h | UTCThe pathogenesis and therapeutic strategies of heat stroke-induced liver injury – Critical Care
Review | Early diagnosis and prevention of infections in cirrhosis
12 Jan, 2023 | 12:47h | UTCEarly Diagnosis and Prevention of Infections in Cirrhosis – Seminars in Liver Disease
Review | Management of acute kidney injury in patients with cirrhosis.
5 Dec, 2022 | 00:11h | UTCManagement of AKI in Patients with Cirrhosis – Current Treatment Options in Gastroenterology
RCT | Rivaroxaban prophylaxis in noncirrhotic portal vein thrombosis.
2 Dec, 2022 | 14:24h | UTCRivaroxaban Prophylaxis in Noncirrhotic Portal Vein Thrombosis – NEJM Evidence
Commentary on Twitter
This #RCT examined the use of rivaroxaban to reduce risk of venous thromboembolism (VTE) in pts with non-cirrhotic chronic portal vein thrombosis (PVT). Daily rivaroxaban reduced incidence of VTE and did not increase major bleeding events. https://t.co/CbenUb8ZWz#LiverTwitter pic.twitter.com/bgN1QS171j
— NEJM Evidence (@NEJMEvidence) November 22, 2022
Review | Public health measures and prevention of alcohol-associated liver disease.
27 Nov, 2022 | 22:14h | UTC
Commentary from one of the authors on Twitter
Public Health Measures and Prevention of Alcohol-Associated Liver Disease @JCEH_Hepatology @LuisAntonioDiaz @FcoIdalsoaga @CokeArnold1 #LiverTwitter https://t.co/8pVLg5Kffp pic.twitter.com/OCrIYgVhJa
— Juan Pablo (JP) Arab, MD (@juanpabloarab) June 28, 2022
KDIGO 2022 Guideline for the prevention, diagnosis, evaluation, and treatment of Hepatitis C in chronic kidney disease.
23 Nov, 2022 | 14:11h | UTCExecutive Summary: KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease – Kidney International
Expert consensus on liver transplantation perioperative evaluation and rehabilitation for acute-on-chronic liver failure.
21 Nov, 2022 | 14:21h | UTC
Portopulmonary hypertension: current developments and future perspectives.
21 Nov, 2022 | 14:20h | UTCPortopulmonary hypertension: Current developments and future perspectives – Liver Research
Related: Pulmonary complications in liver disease – Intensive Care Medicine (free)
Related Reviews:
Pulmonary complications of hepatic diseases – World Journal of Gastroenterology
Phase 2b RCT | Efficacy and safety of Bepirovirsen in chronic Hepatitis B infection.
11 Nov, 2022 | 13:44h | UTCEfficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
In a phase 2 trial, bepirovirsen, an antisense oligonucleotide that targets all hep B virus (HBV) messenger RNAs, resulted in sustained loss of hep B surface antigen and HBV DNA in 9 to 10% of participants with chronic HBV infection. #TLM22 #LiverTwitter https://t.co/krJcMEDhIX pic.twitter.com/SistuAocZO
— NEJM (@NEJM) November 8, 2022
Retrospective Cohort Study | Perinatal outcomes associated with ICP in twin pregnancies were worse than singletons.
11 Nov, 2022 | 13:36h | UTC
M-A | Efficacy and safety of pharmacological interventions for pruritus in primary biliary cholangitis.
8 Nov, 2022 | 11:58h | UTC
Review | Determining prognosis of alcoholic liver disease and alcoholic hepatitis.
4 Nov, 2022 | 13:17h | UTC
ERAS Guidelines for perioperative care for liver surgery.
1 Nov, 2022 | 12:16h | UTCRelated:
Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines
Review | Management of NAFLD in primary care settings.
27 Oct, 2022 | 12:24h | UTCManagement of NAFLD in primary care settings – Liver International
Related:
Non-alcoholic fatty liver disease: A patient guideline – JHEP Reports
Commentary on Twitter
Opportunities of assessment and treatment of #NAFLD in primary care settings
✍️ @VWSWong @DrJavierCrespo @JVLazarus #livertwitter #liverreviews #NASH pic.twitter.com/5SLqNvafAm
— Liver International (@LiverInt) October 23, 2022
AHA Scientific Statement | Emerging evidence on coronary heart disease screening in kidney and liver transplantation candidates.
24 Oct, 2022 | 14:11h | UTCTop Things to Know: Emerging Evidence on Coronary Heart Disease (CHD) Screening in Kidney and Liver Transplantation Candidates – American Heart Association
Case-control study | Post-paracentesis ascitic fluid leak in patients with cirrhosis of liver and its management.
21 Oct, 2022 | 12:57h | UTC
M-A of RCT | Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis.
20 Oct, 2022 | 12:25h | UTCCarvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis – Journal of Hepatology (link to abstract – $ for full-text)
Commentary on Twitter
#Carvedilol
➡️non-selective #βblocker
✅associated with reduced risk of decompensating events
➡️improved survival in patients with #cirrhosis & #portalhypertensionRead it here👉https://t.co/yy8DIJBhfL#LiverTwitter pic.twitter.com/XxmrB7gff8
— Journal of Hepatology (@JHepatology) October 13, 2022
Choosing Wisely | Top five list of procedures to avoid in the treatment of viral hepatitis.
7 Oct, 2022 | 14:22h | UTCSee complete lists of low-value practices: Choosing Wisely U.S. / Choosing Wisely UK / Choosing Wisely Australia AND Choosing Wisely Canada
Baveno VII – Renewing consensus in portal hypertension.
7 Oct, 2022 | 14:17h | UTCBaveno VII – Renewing consensus in portal hypertension – Journal of Hepatology
RCT | Trientine tetrahydrochloride noninferior to penicillamine for maintenance therapy in Wilson disease.
7 Oct, 2022 | 14:10h | UTCTrientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial – The Lancet Gastroenterology & Hepatology (link to abstract – $ for full-text)
Commentary on Twitter
New research – Schilsky et al – Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial https://t.co/OS0kh2EkM0#livertwitter #wilsonsdisease #wilsondisease pic.twitter.com/Grizm2uN7F
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) September 30, 2022
Review | Alcohol and acute-on-chronic liver failure.
4 Oct, 2022 | 14:33h | UTCAlcohol and Acute-on-Chronic Liver Failure – Journal of Clinical and Experimental Hepatology
Related:
Acute-on-Chronic Liver Failure Clinical Guidelines – American Journal of Gastroenterology
Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU
Supplement | The role of liver transplantation in acute-on-chronic liver failure.
Review | Acute kidney injury in patients with liver disease.
3 Oct, 2022 | 13:56h | UTC
Commentary on Twitter
AKI is commonly encountered in patients with decompensated cirrhosis, and it is associated with unfavorable outcomes. This article discusses tailoring management of AKI in patients with liver disease to the specific underlying etiology https://t.co/UVEeYBL8ff@VelezNephHepato pic.twitter.com/V5J8hBQyuw
— CJASN (@CJASN) September 27, 2022
Critical care hepatology: definitions, incidence, prognosis and role of liver failure in critically ill patients.
28 Sep, 2022 | 13:37h | UTC
Practice Guidance | A multidisciplinary approach to the diagnosis and management of Wilson Disease.
27 Sep, 2022 | 13:13h | UTC